1. Home
  2. IONS
  3. IONS News

Latest Ionis Pharmaceuticals Inc. (IONS) News on February 22, 2025

Ionis Pharmaceuticals price target lowered to $60 from $61 at Raymond James
IONS

TipRanks

a day ago

Ionis Pharmaceuticals price target lowered to $60 from $61 at Raymond James

Why Ionis Pharmaceuticals (IONS) Is Among the Most Oversold Healthcare Stocks to Buy Now
IONS

Insider Monkey

2 days ago

Why Ionis Pharmaceuticals (IONS) Is Among the Most Oversold Healthcare Stocks to Buy Now

Ionis' Q4 Earnings and Sales Beat Estimates, Tryngolza Launch in Focus
IONS

Zacks

2 days ago

Ionis' Q4 Earnings and Sales Beat Estimates, Tryngolza Launch in Focus

IONS

Morningstar Research

2 days ago

Analyst Report: Ionis Pharmaceuticals, Inc.

New positive donidalorsen data to be presented at AAAAI/WAO Joint Congress highlight sustained HAE attack rate reduction and disease control
IONS

Business Wire

2 days ago

New positive donidalorsen data to be presented at AAAAI/WAO Joint Congress highlight sustained HAE attack rate reduction and disease control

Ionis Pharmaceuticals Full Year 2024 Earnings: Beats Expectations
IONS

Simply Wall St.

2 days ago

Ionis Pharmaceuticals Full Year 2024 Earnings: Beats Expectations

IONS

Thomson Reuters StreetEvents

2 days ago

Q4 2024 Ionis Pharmaceuticals Inc Earnings Call

Ionis Pharmaceuticals Inc (IONS) Q4 2024 Earnings Call Highlights: Surpassing Revenue ...
IONS

GuruFocus.com

3 days ago

Ionis Pharmaceuticals Inc (IONS) Q4 2024 Earnings Call Highlights: Surpassing Revenue ...

Ionis Pharmaceuticals Q4 Revenue Growth Exceeds Guidance, Forecasts Over $600 Million In 2025 Sales
IONS

Benzinga

3 days ago

Ionis Pharmaceuticals Q4 Revenue Growth Exceeds Guidance, Forecasts Over $600 Million In 2025 Sales

Ionis Pharmaceuticals (IONS) Reports Q4 Earnings: What Key Metrics Have to Say
IONS

Zacks

3 days ago

Ionis Pharmaceuticals (IONS) Reports Q4 Earnings: What Key Metrics Have to Say

Ionis Pharmaceuticals (IONS) Reports Q4 Loss, Tops Revenue Estimates
IONS

Zacks

3 days ago

Ionis Pharmaceuticals (IONS) Reports Q4 Loss, Tops Revenue Estimates

IONS

MT Newswires

3 days ago

Ionis Pharmaceuticals Q4 Net Loss Widens, Revenue Falls; 2025 Sales Guidance Set

IONS

Associated Press Finance

3 days ago

Ionis Pharmaceuticals: Q4 Earnings Snapshot

Ionis reports fourth quarter and full year 2024 financial results
IONS

Business Wire

3 days ago

Ionis reports fourth quarter and full year 2024 financial results

Ionis Pharmaceuticals (IONS): Among Top Insider Stock Buys And Sells In January
IONS

Insider Monkey

4 days ago

Ionis Pharmaceuticals (IONS): Among Top Insider Stock Buys And Sells In January

Exploring Analyst Estimates for Ionis Pharmaceuticals (IONS) Q4 Earnings, Beyond Revenue and EPS
IONS

Zacks

5 days ago

Exploring Analyst Estimates for Ionis Pharmaceuticals (IONS) Q4 Earnings, Beyond Revenue and EPS

Ionis Pharmaceuticals (IONS) Expected to Beat Earnings Estimates: Should You Buy?
IONS

Zacks

10 days ago

Ionis Pharmaceuticals (IONS) Expected to Beat Earnings Estimates: Should You Buy?

Why Insiders Are Selling Ionis Pharmaceuticals, Inc. (IONS) Recently
IONS

Insider Monkey

11 days ago

Why Insiders Are Selling Ionis Pharmaceuticals, Inc. (IONS) Recently

Why Ionis Pharmaceuticals, Inc. (IONS) Is Among the Best Healthcare Stocks To Buy According to Analysts
IONS

Insider Monkey

14 days ago

Why Ionis Pharmaceuticals, Inc. (IONS) Is Among the Best Healthcare Stocks To Buy According to Analysts

IONS

MT Newswires

16 days ago

Ionis Pharmaceuticals Insider Sold Shares Worth $1,229,463, According to a Recent SEC Filing

Ionis to hold fourth quarter and full year 2024 financial results webcast
IONS

Business Wire

17 days ago

Ionis to hold fourth quarter and full year 2024 financial results webcast

IONS

MT Newswires

22 days ago

Ionis Pharmaceuticals Says Data Readout From Pelacarsen Study Is Delayed

FDA and EMA Accept Applications for Higher Dose Regimen of Nusinersen in SMA
IONS

GlobeNewswire

a month ago

FDA and EMA Accept Applications for Higher Dose Regimen of Nusinersen in SMA

IONS

Argus Research

a month ago

Daily – Vickers Top Buyers & Sellers for 01/21/2025

IONS

MT Newswires

a month ago

Ionis Pharmaceuticals Insider Sold Shares Worth $1,091,444, According to a Recent SEC Filing

Why Ionis Pharmaceuticals (IONS) Is the Biotech Stock with Biggest Upside Potential
IONS

Insider Monkey

a month ago

Why Ionis Pharmaceuticals (IONS) Is the Biotech Stock with Biggest Upside Potential

Ionis enters new chapter in 2025 as commercial-stage biotech with multiple independent product launches anticipated and continued late-stage pipeline momentum
IONS

PR Newswire

a month ago

Ionis enters new chapter in 2025 as commercial-stage biotech with multiple independent product launches anticipated and continued late-stage pipeline momentum

Catalyst (CPRX) Soars 16.7%: Is Further Upside Left in the Stock?
IONS

Zacks

a month ago

Catalyst (CPRX) Soars 16.7%: Is Further Upside Left in the Stock?

Ionis to present at 43rd Annual J.P. Morgan Healthcare Conference
IONS

PR Newswire

a month ago

Ionis to present at 43rd Annual J.P. Morgan Healthcare Conference

Are Investors Undervaluing Ionis Pharmaceuticals, Inc. (NASDAQ:IONS) By 30%?
IONS

Simply Wall St.

2 months ago

Are Investors Undervaluing Ionis Pharmaceuticals, Inc. (NASDAQ:IONS) By 30%?

IONS

Morningstar Research

2 months ago

Morningstar | A Weekly Summary of Stock Ideas and Developments in the Companies We Cover

IONS

Morningstar Research

2 months ago

Analyst Report: Ionis Pharmaceuticals, Inc.

FDA approves Ionis’ TRYNGOLZA for FCS treatment
IONS

Pharmaceutical Technology

2 months ago

FDA approves Ionis’ TRYNGOLZA for FCS treatment

Ionis Gets FDA Approval for Rare Disease Drug Tryngolza
IONS

Zacks

2 months ago

Ionis Gets FDA Approval for Rare Disease Drug Tryngolza

FDA Approves Ionis Pharmaceuticals' Rare Genetic Disease Therapy to Lower High-Level Of Fat In Blood
IONS

Benzinga

2 months ago

FDA Approves Ionis Pharmaceuticals' Rare Genetic Disease Therapy to Lower High-Level Of Fat In Blood

Ionis gets a milestone approval; Another top FDA official to step down
IONS

BioPharma Dive

2 months ago

Ionis gets a milestone approval; Another top FDA official to step down

IONS

MT Newswires

2 months ago

Ionis Pharmaceuticals Says FDA Approved Familial Chylomicronemia Syndrome Drug

TRYNGOLZA™ (olezarsen) approved in U.S. as first-ever treatment for adults living with familial chylomicronemia syndrome as an adjunct to diet
IONS

PR Newswire

2 months ago

TRYNGOLZA™ (olezarsen) approved in U.S. as first-ever treatment for adults living with familial chylomicronemia syndrome as an adjunct to diet

Theravance Bio (TBPH) Up 3.7% Since Last Earnings Report: Can It Continue?
IONS

Zacks

2 months ago

Theravance Bio (TBPH) Up 3.7% Since Last Earnings Report: Can It Continue?

How Much Upside is Left in Ionis Pharmaceuticals (IONS)? Wall Street Analysts Think 55.91%
IONS

Zacks

2 months ago

How Much Upside is Left in Ionis Pharmaceuticals (IONS)? Wall Street Analysts Think 55.91%

IONS

Morningstar Research

2 months ago

Analyst Report: Ionis Pharmaceuticals, Inc.

Ionis Pharmaceuticals (IONS) Down 4.5% Since Last Earnings Report: Can It Rebound?
IONS

Zacks

3 months ago

Ionis Pharmaceuticals (IONS) Down 4.5% Since Last Earnings Report: Can It Rebound?

Theratechnologies enters exclusive licensing agreement with Ionis
IONS

TipRanks

3 months ago

Theratechnologies enters exclusive licensing agreement with Ionis

IONS

MT Newswires

3 months ago

Theratechnologies to Commercialize Two RNA-targeted Medicines in Canada

IONS

MT Newswires

3 months ago

Theratechnologies Acquires Canadian Rights to 2 RNA Medicines From Ionis Pharmaceuticals

Ionis Pharmaceuticals (IONS) Upgraded to Buy: What Does It Mean for the Stock?
IONS

Zacks

3 months ago

Ionis Pharmaceuticals (IONS) Upgraded to Buy: What Does It Mean for the Stock?

Why Is Ionis Pharmaceuticals, Inc. (IONS) Among the Worst Performing Biotech Stocks in 2024?
IONS

Insider Monkey

3 months ago

Why Is Ionis Pharmaceuticals, Inc. (IONS) Among the Worst Performing Biotech Stocks in 2024?

Ionis Pharmaceuticals, Inc. (IONS): Among the Best Genomics Stocks to Buy Right Now
IONS

Insider Monkey

3 months ago

Ionis Pharmaceuticals, Inc. (IONS): Among the Best Genomics Stocks to Buy Right Now

Here's Why Ionis Pharmaceuticals (IONS) is Poised for a Turnaround After Losing -13.46% in 4 Weeks
IONS

Zacks

3 months ago

Here's Why Ionis Pharmaceuticals (IONS) is Poised for a Turnaround After Losing -13.46% in 4 Weeks

Ionis Pharmaceuticals Third Quarter 2024 Earnings: Beats Expectations
IONS

Simply Wall St.

3 months ago

Ionis Pharmaceuticals Third Quarter 2024 Earnings: Beats Expectations

Ionis' Q3 Earnings and Revenues Beat Estimates, New Launches in Focus
IONS

Zacks

3 months ago

Ionis' Q3 Earnings and Revenues Beat Estimates, New Launches in Focus

Company News for Nov 7, 2024
IONS

Zacks

3 months ago

Company News for Nov 7, 2024

Ionis to present at upcoming investor conferences
IONS

PR Newswire

3 months ago

Ionis to present at upcoming investor conferences

Ionis announces design for Phase III trial of Angelman syndrome therapy
IONS

Clinical Trials Arena

3 months ago

Ionis announces design for Phase III trial of Angelman syndrome therapy

IONS

Thomson Reuters StreetEvents

3 months ago

Q3 2024 Ionis Pharmaceuticals Inc Earnings Call

Ionis Pharmaceuticals Inc (IONS) Q3 2024 Earnings Call Highlights: Navigating Revenue ...
IONS

GuruFocus.com

4 months ago

Ionis Pharmaceuticals Inc (IONS) Q3 2024 Earnings Call Highlights: Navigating Revenue ...

IONS

MT Newswires

4 months ago

Ionis Reports Late-Stage Trial Design in Angelman Syndrome

Intellia Therapeutics Just Notched Another Win. So Why Did Its Stock Fall 18% in 1 Day?
IONS

Motley Fool

4 months ago

Intellia Therapeutics Just Notched Another Win. So Why Did Its Stock Fall 18% in 1 Day?

Compared to Estimates, Ionis Pharmaceuticals (IONS) Q3 Earnings: A Look at Key Metrics
IONS

Zacks

4 months ago

Compared to Estimates, Ionis Pharmaceuticals (IONS) Q3 Earnings: A Look at Key Metrics

Ionis Pharmaceuticals (IONS) Reports Q3 Loss, Tops Revenue Estimates
IONS

Zacks

4 months ago

Ionis Pharmaceuticals (IONS) Reports Q3 Loss, Tops Revenue Estimates

IONS

MT Newswires

4 months ago

Ionis Pharmaceuticals' Q3 Loss Narrows, Revenue Decreases

IONS

Associated Press Finance

4 months ago

Ionis Pharmaceuticals: Q3 Earnings Snapshot

Ionis Announces Pivotal Phase 3 Trial Design for ION582 in Angelman Syndrome
IONS

PR Newswire

4 months ago

Ionis Announces Pivotal Phase 3 Trial Design for ION582 in Angelman Syndrome

Ionis reports third quarter 2024 financial results
IONS

PR Newswire

4 months ago

Ionis reports third quarter 2024 financial results

IONS

MT Newswires

4 months ago

Ionis Pharmaceuticals Gets FDA Acceptance of New Drug Application for Angioedema Treatment

Ionis announces FDA acceptance of New Drug Application for donidalorsen for prophylactic treatment of HAE
IONS

PR Newswire

4 months ago

Ionis announces FDA acceptance of New Drug Application for donidalorsen for prophylactic treatment of HAE

Countdown to Ionis Pharmaceuticals (IONS) Q3 Earnings: A Look at Estimates Beyond Revenue and EPS
IONS

Zacks

4 months ago

Countdown to Ionis Pharmaceuticals (IONS) Q3 Earnings: A Look at Estimates Beyond Revenue and EPS

Karyopharm Therapeutics (KPTI) May Report Negative Earnings: Know the Trend Ahead of Q3 Release
IONS

Zacks

4 months ago

Karyopharm Therapeutics (KPTI) May Report Negative Earnings: Know the Trend Ahead of Q3 Release

Ionis Pharmaceuticals (IONS) Expected to Beat Earnings Estimates: Can the Stock Move Higher?
IONS

Zacks

4 months ago

Ionis Pharmaceuticals (IONS) Expected to Beat Earnings Estimates: Can the Stock Move Higher?

Ionis Pharmaceuticals' (NASDAQ:IONS) investors will be pleased with their 30% return over the last three years
IONS

Simply Wall St.

4 months ago

Ionis Pharmaceuticals' (NASDAQ:IONS) investors will be pleased with their 30% return over the last three years

Ionis to hold third quarter 2024 financial results webcast
IONS

PR Newswire

4 months ago

Ionis to hold third quarter 2024 financial results webcast

EU CHMP recommends AstraZeneca and Ionis’ Wainzua for ATTRv-PN
IONS

Pharmaceutical Technology

4 months ago

EU CHMP recommends AstraZeneca and Ionis’ Wainzua for ATTRv-PN

IONS

MT Newswires

4 months ago

Ionis Pharmaceuticals Says Wainzua Recommended for Approval in European Union

WAINZUA (eplontersen) recommended for approval in the EU by CHMP for the treatment of adults with polyneuropathy associated with hereditary transthyretin-mediated amyloidosis
IONS

PR Newswire

4 months ago

WAINZUA (eplontersen) recommended for approval in the EU by CHMP for the treatment of adults with polyneuropathy associated with hereditary transthyretin-mediated amyloidosis

Ionis Pharmaceuticals, Inc. (IONS): Among The Stocks With Biggest Upside Potential According to Hedge Funds
IONS

Insider Monkey

4 months ago

Ionis Pharmaceuticals, Inc. (IONS): Among The Stocks With Biggest Upside Potential According to Hedge Funds

New Higher Dose Nusinersen Efficacy and Safety Data Presented at World Muscle Society Congress, Highlight Potential to Maximize Benefit of Nusinersen in SMA
IONS

GlobeNewswire

4 months ago

New Higher Dose Nusinersen Efficacy and Safety Data Presented at World Muscle Society Congress, Highlight Potential to Maximize Benefit of Nusinersen in SMA

New positive donidalorsen data to be presented at 2024 American College of Allergy, Asthma & Immunology (ACAAI) Annual Scientific Meeting
IONS

PR Newswire

5 months ago

New positive donidalorsen data to be presented at 2024 American College of Allergy, Asthma & Immunology (ACAAI) Annual Scientific Meeting

IONS' Rare Neurology Disorder Candidate Gets FDA's Fast Track Tag
IONS

Zacks

5 months ago

IONS' Rare Neurology Disorder Candidate Gets FDA's Fast Track Tag

IONS

Morningstar Research

5 months ago

Analyst Report: Ionis Pharmaceuticals, Inc.

IONS

MT Newswires

5 months ago

Ionis Pharmaceuticals Says FDA Granted Fast Track Designation to Zilganersen to Treat Alexander Disease

Zilganersen granted U.S. FDA Fast Track designation for people living with Alexander disease
IONS

PR Newswire

5 months ago

Zilganersen granted U.S. FDA Fast Track designation for people living with Alexander disease

The Brawl Taking Shape Over Pfizer’s Multibillion-Dollar Heart Monopoly
IONS

The Wall Street Journal

5 months ago

The Brawl Taking Shape Over Pfizer’s Multibillion-Dollar Heart Monopoly

Ionis Stock Drops 12% on Pricing of $500M Common Stock Offering
IONS

Zacks

5 months ago

Ionis Stock Drops 12% on Pricing of $500M Common Stock Offering

IONS

MT Newswires

5 months ago

Update: Ionis Pharmaceuticals Shares Fall After Pricing of $500.3 Million Stock Offering

IONS

MT Newswires

5 months ago

Sector Update: Health Care Stocks Flat to Higher Premarket Tuesday

IONS

MT Newswires

5 months ago

Ionis Pharmaceuticals Prices $500.3 Million Public Offering at $43.50 a Share

Ionis announces pricing of $500.3 million public offering
IONS

PR Newswire

5 months ago

Ionis announces pricing of $500.3 million public offering

IONS

MT Newswires

5 months ago

Ionis Pharmaceuticals Plans $500 Million Common Stock Offering; Shares Fall After Hours

Ionis announces proposed public offering of common stock
IONS

PR Newswire

5 months ago

Ionis announces proposed public offering of common stock

Why Is Zoetis (ZTS) Up 1.4% Since Last Earnings Report?
IONS

Zacks

6 months ago

Why Is Zoetis (ZTS) Up 1.4% Since Last Earnings Report?

Theravance Bio (TBPH) Up 2.2% Since Last Earnings Report: Can It Continue?
IONS

Zacks

6 months ago

Theravance Bio (TBPH) Up 2.2% Since Last Earnings Report: Can It Continue?

Praxis Precision Medicines to highlight their Epilepsy Portfolio at the International League Against Epilepsy 15th European Epilepsy Congress with six presentations
IONS

GlobeNewswire

6 months ago

Praxis Precision Medicines to highlight their Epilepsy Portfolio at the International League Against Epilepsy 15th European Epilepsy Congress with six presentations

Biogen Announces Positive Topline Results from Study of Higher Dose Regimen of Nusinersen, Showing Significant Benefit in Treatment of SMA
IONS

GlobeNewswire

6 months ago

Biogen Announces Positive Topline Results from Study of Higher Dose Regimen of Nusinersen, Showing Significant Benefit in Treatment of SMA

Ionis to present at upcoming investor conferences
IONS

PR Newswire

6 months ago

Ionis to present at upcoming investor conferences

Will Ionis' (IONS) Wholly-Owned Drugs Drive Future Growth?
IONS

Zacks

6 months ago

Will Ionis' (IONS) Wholly-Owned Drugs Drive Future Growth?

Insider Sale at Ionis Pharmaceuticals Inc (IONS) by EVP, Chief Development Officer Richard Geary
IONS

GuruFocus.com

7 months ago

Insider Sale at Ionis Pharmaceuticals Inc (IONS) by EVP, Chief Development Officer Richard Geary

Ionis Pharmaceuticals Second Quarter 2024 Earnings: Beats Expectations
IONS

Simply Wall St.

7 months ago

Ionis Pharmaceuticals Second Quarter 2024 Earnings: Beats Expectations

IONS

Morningstar Research

7 months ago

Analyst Report: Ionis Pharmaceuticals, Inc.

Ionis (IONS) Q2 Earnings and Revenues Beat, Stock Rises
IONS

Zacks

7 months ago

Ionis (IONS) Q2 Earnings and Revenues Beat, Stock Rises

IONS

MT Newswires

7 months ago

BMO Capital Downgrades Ionis Pharmaceuticals to Market Perform From Outperform, Adjusts PT to $60 From $67

Share on Social Networks: